Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Oxy2Pro

K-Number: K222511 · 2023-11-21

Decision Date2023-11-21
Product CodeCCK
Advisory CommitteeAN
DecisionSubstantially Equivalent

Device Summary

Oxy2Pro is a medical device manufactured by Southmedic, Inc.. It received FDA 510(k) clearance on 2023-11-21 under approval number K222511. The device is classified under product code CCK. It was reviewed by the AN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Oxy2Pro?

Oxy2Pro is a medical device that received FDA 510(k) clearance on 2023-11-21. It is manufactured by Southmedic, Inc.. The 510(k) number is K222511.

When was Oxy2Pro approved by the FDA?

Oxy2Pro received FDA 510(k) clearance on 2023-11-21, under approval number K222511.

What company makes Oxy2Pro?

Oxy2Pro is manufactured by Southmedic, Inc..

What is the FDA product code for Oxy2Pro?

The FDA product code for Oxy2Pro is CCK.

Related Devices (Code: CCK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.